Gunther Birznieks's most recent trade in Vanda Pharmaceuticals Inc was a trade of 26,941 Common Stock done at an average price of $4.8 . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.76 per share. | 01 Mar 2025 | 26,941 | 411,628 (0%) | 0% | 4.8 | 128,239 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 125,000 | 438,569 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 04 Mar 2024 | 8,727 | 322,253 (0%) | 0% | 4.3 | 37,495 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 04 Mar 2024 | 8,684 | 313,569 (0%) | 0% | 4.1 | 35,884 | Common Stock |
| Vanda Pharmaceuticals Inc | Birznieks Gunther | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 125,000 | 330,980 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 6.20 per share. | 02 Mar 2023 | 8,509 | 214,248 (0%) | 0% | 6.2 | 52,793 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 02 Mar 2023 | 8,268 | 205,980 (0%) | 0% | 6.3 | 51,791 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 32,700 | 222,757 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 26 Aug 2022 | 1,250 | 190,057 (0%) | 0% | 3.1 | 3,900 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 1,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,700 | 204,408 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 11.27 per share. | 28 Feb 2022 | 11,517 | 188,807 (0%) | 0% | 11.3 | 129,792 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 28 Feb 2022 | 4,084 | 200,324 (0%) | 0% | 11.2 | 45,700 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 18.19 per share. | 01 Mar 2021 | 16,620 | 171,708 (0%) | 0% | 18.2 | 302,273 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Sale of securities on an exchange or to another person at price $ 18.66 per share. | 01 Mar 2021 | 3,845 | 188,328 (0%) | 0% | 18.7 | 71,744 | Common Stock |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 77,500 | 77,500 | - | - | Employee Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Gunther Birznieks | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 32,700 | 192,173 (0%) | 0% | - | Common Stock |